Edesa Biotech is trading 5.39% down at $3.69 amid broader risk-off pressure, with no verified company-specific catalyst identified. - The supplied market context shows major indexes lower and the biotech sector down 2.04%. - No confirmed company-specific announcement was identified for October 8, 2026; the company’s news page lists its latest releases as older than this session.